New Delhi, April 30 -- The US Food and Drug Administration (FDA) has approved Johnson & Johnson's drug to treat patients aged 12 years and older with an immune-mediated disorder, the drugmaker said on Wednesday.

Published by HT Digital Content Services with permission from MINT....